RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?
RAPT Therapeutics Ownership Summary
RAPT Therapeutics is owned by 76.60% institutional investors, 1.84% insiders, and 21.56% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 57.45% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.
RAPT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | RAPT Therapeutics | 76.60% | 1.84% | 21.56% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Medicxi ventures management (jersey) | 22.35M | 57.45% | $35.32M |
Fmr | 5.24M | 13.55% | $15.97M |
Vanguard group | 3.11M | 8.05% | $9.48M |
Column group | 2.68M | 6.94% | $8.18M |
Blackrock | 2.44M | 6.32% | $7.44M |
Kingdon capital management | 1.73M | 4.47% | $5.26M |
Morgan stanley | 1.18M | 3.05% | $3.60M |
Deutsche bank ag\ | 932.54K | 2.41% | $2.84M |
D. e. shaw | 907.41K | 2.35% | $2.77M |
Federated hermes | 796.08K | 2.06% | $2.43M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Column group | 2.68M | 11.47% | $8.18M |
Medicxi ventures management (jersey) | 22.35M | 6.68% | $35.32M |
Kingdon capital management | 1.73M | 0.56% | $5.26M |
Ghost tree capital | 300.00K | 0.29% | $915.00K |
Sio capital management | 315.00K | 0.26% | $960.75K |
Euclidean capital | 657.90K | 0.25% | $2.01M |
Altium capital management lp | 200.00K | 0.25% | $610.00K |
Octagon capital advisors lp | 292.00K | 0.14% | $890.60K |
Redmile group | 536.68K | 0.10% | $1.64M |
Cormorant asset management, lp | 496.75K | 0.09% | $1.52M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Medicxi ventures management (jersey) | 22.35M | 6.68% | 22.35M |
Point72 asset management | 707.30K | 0.01% | 706.90K |
Deutsche bank ag\ | 932.54K | 0.00% | 643.03K |
D. e. shaw | 907.41K | 0.00% | 637.27K |
Vanguard group | 3.11M | 0.00% | 615.42K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Price t rowe associates inc /md/ | 208.50K | 0.00% | -1.82M |
Perceptive advisors | - | - | -1.22M |
Morgan stanley | 1.18M | 0.00% | -726.44K |
Ardsley advisory partners lp | - | - | -500.00K |
Ally bridge group (ny) | - | - | -420.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Medicxi ventures management (jersey) | 22.35M | 6.68% | 22.35M | $35.32M |
Altium capital management lp | 200.00K | 0.25% | 200.00K | $610.00K |
Norges bank | 100.30K | - | 100.30K | $305.92K |
Pdt partners | 97.81K | 0.03% | 97.81K | $298.31K |
Aqr capital management | 88.37K | 0.00% | 88.37K | $269.54K |
Sold Out
Holder | Change |
---|---|
Farther finance advisors | -2.00 |
Nelson, van denburg & campbell wealth management group | -7.00 |
Gamma investing | -27.00 |
Capital performance advisors llp | -34.00 |
Quadrant capital group | -38.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 95 | -18.10% | 29,799,990 | -6.32% | 76 | 1.13% | 38 | -32.14% | 27 | -18.18% |
Jun 30, 2024 | 116 | -17.14% | 31,809,166 | -0.17% | 82 | 1.20% | 56 | -25.33% | 33 | 10.00% |
Mar 31, 2024 | 140 | 19.66% | 31,861,728 | -8.92% | 83 | 1.00% | 75 | 19.05% | 30 | -14.29% |
Dec 31, 2023 | 117 | 15.84% | 34,982,126 | 0.63% | 91 | 1.11% | 63 | 50.00% | 35 | -7.89% |
Sep 30, 2023 | 101 | 1.00% | 34,763,427 | 2.09% | 90 | 1.15% | 42 | -12.50% | 38 | 15.15% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 2.00M | 5.73% | - |
Vanguard Total Stock Mkt Idx Inv | 1.05M | 3.00% | - |
Fidelity Growth Compy Commingled Pl S | 2.05M | 1.56% | 21.11K |
Federated Hermes MDT SCC Institutional | 461.23K | 1.32% | - |
Federated Hermes MDT Small Cap Core IS | 461.23K | 1.32% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 458.85K | 1.31% | - |
Fidelity Growth Company Fund | 1.49M | 1.13% | -18.17K |
Federated Hermes MDT Small Cap Growth IS | 306.29K | 0.88% | - |
Federated Hermes MDT SCG Institutional | 306.29K | 0.88% | - |
Fidelity Select Biotechnology | 802.70K | 0.61% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 05, 2024 | Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | Sell | $20.46K |
Dec 21, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $54.20K |
Nov 28, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $20.58K |
Oct 03, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $39.42K |
Aug 18, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $47.30K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 1 |
2023 Q4 | - | 3 |
2023 Q3 | - | 1 |
RAPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools